Spain investigates obesity surgery safety:
This article was originally published in Clinica
Executive Summary
The Spanish health ministry has launched an enquiry into the use of surgical treatments of morbid obesity, amid safety concerns. Almost 3,000 cases were diagnosed in 2002, of which 1,500 underwent surgery, most commonly gastric bypass. Of these patients, 15 (1%) died, according to the health ministry. But Spanish experts believe that 10% of cases suffer serious complications, with mortality rising to 2%. At least seven deaths have been recorded this year. Some 1.5% of Spaniards are morbidly obese (defined as a body mass index of over 40, when a normal weight is an index of 25), according to the national society for the study of obesity (SEEO), which believes that the number of diagnoses is currently rising by around 50% a year.
You may also be interested in...
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip
With One Launch Under Way, SpringWorks Ramps Up For A Second
The company initiated a rolling submission with the US FDA for mirdametinib, a MEK inhibitor that is poised to be its second commercial product for a rare disease.